drugset / Trial / NCT06798363

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

NCT06798363

Phase 2/3 Recruiting 40 enrolled West China Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).

Timeline

Start
2025-05-02
Primary completion
2026-06-30
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 1 mg/kg
Subject Propranolol Small molecule 2 mg/kg

Indications